The folate cycle is a new metabolic weakness of cancer

Derek Lee,Carmen Chak-Lui Wong
DOI: https://doi.org/10.1080/23723556.2017.1327004
2017-10-23
Abstract:Cancer cells harness nutrients to support its rapid proliferation through metabolic reprogramming. Our report identified folate cycle as a metabolic target in hepatocellular carcinoma. Folate cycle stagnation via inhibition of its mitochondrial folate enzyme methylenetetrahydrofolate dehydrogenase 1-like (MTHFD1L) greatly induced oxidative stress improving HCC cells' response to sorafenib.
What problem does this paper attempt to address?